In the Supplementary Information of this Article, on pages 3, 8 and 11, we refer to “UK Patent Application No. 1522431.4”, which pertains to the discovery of the truncated peptide analogues we used1, and specifically to the use of the modified N terminus or ‘Cap’. This patent application mentions another patent, which we cite here2. The original Article has not been corrected.
Andrews, A., Congreve, M., Bortolato, A. & Mason, J. Novel GLP-1 receptor agonist peptides. UK patent application GB1522431.4 (2017)
Kodra, J. T. & Madsen, J. GLP-1 receptor agonist compounds with a modified N-terminus. Worldwide patent WO2011073328 (2011)
The online version of the original article can be found at 10.1038/nature22800
About this article
Cite this article
Jazayeri, A., Rappas, M., Brown, A. et al. Correction: Corrigendum: Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature 548, 122 (2017). https://doi.org/10.1038/nature23311
Nature Communications (2020)